PTHrP gene expression in cancer: Do all paths lead to Ets?

Virgile Richard, Thomas J. Rosol, John Foley

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Parathyroid hormone-related protein (PTHrP) came to the attention of the scientific community in the mid-1980s because of its association with the paraneoplastic syndrome of humoral hypercalcemia of malignancy. Recently, a crucial role for the peptide has been identified in the metastatic growth of cancer cells in bone. Efforts to understand the peptide's role in these pathological processes have evolved into the study of PTHrP gene expression. Currently, regulation of the third PTHrP promoter is beginning to be understood in the context of activation of certain signaling pathways involved in the growth and progression of specific neoplasms. In addition, factors that modulate the entire PTHrP-transcriptional unit, as well as the stability of the mRNA, are being elucidated at the level of cis-acting sequences.

Original languageEnglish
Pages (from-to)115-132
Number of pages18
JournalCritical Reviews in Eukaryotic Gene Expression
Volume15
Issue number2
DOIs
StatePublished - 2005

Fingerprint

Parathyroid Hormone-Related Protein
Gene Expression
Neoplasms
Paraneoplastic Syndromes
Peptides
RNA Stability
Pathologic Processes
Growth
Bone and Bones

Keywords

  • Bone metastasis
  • HTLV-1
  • Hypercalcemia
  • Ras-MapK
  • TGF-β
  • Vitamin D

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

PTHrP gene expression in cancer : Do all paths lead to Ets? / Richard, Virgile; Rosol, Thomas J.; Foley, John.

In: Critical Reviews in Eukaryotic Gene Expression, Vol. 15, No. 2, 2005, p. 115-132.

Research output: Contribution to journalArticle

Richard, Virgile ; Rosol, Thomas J. ; Foley, John. / PTHrP gene expression in cancer : Do all paths lead to Ets?. In: Critical Reviews in Eukaryotic Gene Expression. 2005 ; Vol. 15, No. 2. pp. 115-132.
@article{5c0acf6eba5841e2b05dccee4accd5ab,
title = "PTHrP gene expression in cancer: Do all paths lead to Ets?",
abstract = "Parathyroid hormone-related protein (PTHrP) came to the attention of the scientific community in the mid-1980s because of its association with the paraneoplastic syndrome of humoral hypercalcemia of malignancy. Recently, a crucial role for the peptide has been identified in the metastatic growth of cancer cells in bone. Efforts to understand the peptide's role in these pathological processes have evolved into the study of PTHrP gene expression. Currently, regulation of the third PTHrP promoter is beginning to be understood in the context of activation of certain signaling pathways involved in the growth and progression of specific neoplasms. In addition, factors that modulate the entire PTHrP-transcriptional unit, as well as the stability of the mRNA, are being elucidated at the level of cis-acting sequences.",
keywords = "Bone metastasis, HTLV-1, Hypercalcemia, Ras-MapK, TGF-β, Vitamin D",
author = "Virgile Richard and Rosol, {Thomas J.} and John Foley",
year = "2005",
doi = "10.1615/CritRevEukaryotGeneExpr.v15.i2.30",
language = "English",
volume = "15",
pages = "115--132",
journal = "Critical Reviews in Eukaryotic Gene Expression",
issn = "1045-4403",
publisher = "Begell House Inc.",
number = "2",

}

TY - JOUR

T1 - PTHrP gene expression in cancer

T2 - Do all paths lead to Ets?

AU - Richard, Virgile

AU - Rosol, Thomas J.

AU - Foley, John

PY - 2005

Y1 - 2005

N2 - Parathyroid hormone-related protein (PTHrP) came to the attention of the scientific community in the mid-1980s because of its association with the paraneoplastic syndrome of humoral hypercalcemia of malignancy. Recently, a crucial role for the peptide has been identified in the metastatic growth of cancer cells in bone. Efforts to understand the peptide's role in these pathological processes have evolved into the study of PTHrP gene expression. Currently, regulation of the third PTHrP promoter is beginning to be understood in the context of activation of certain signaling pathways involved in the growth and progression of specific neoplasms. In addition, factors that modulate the entire PTHrP-transcriptional unit, as well as the stability of the mRNA, are being elucidated at the level of cis-acting sequences.

AB - Parathyroid hormone-related protein (PTHrP) came to the attention of the scientific community in the mid-1980s because of its association with the paraneoplastic syndrome of humoral hypercalcemia of malignancy. Recently, a crucial role for the peptide has been identified in the metastatic growth of cancer cells in bone. Efforts to understand the peptide's role in these pathological processes have evolved into the study of PTHrP gene expression. Currently, regulation of the third PTHrP promoter is beginning to be understood in the context of activation of certain signaling pathways involved in the growth and progression of specific neoplasms. In addition, factors that modulate the entire PTHrP-transcriptional unit, as well as the stability of the mRNA, are being elucidated at the level of cis-acting sequences.

KW - Bone metastasis

KW - HTLV-1

KW - Hypercalcemia

KW - Ras-MapK

KW - TGF-β

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=24644457061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644457061&partnerID=8YFLogxK

U2 - 10.1615/CritRevEukaryotGeneExpr.v15.i2.30

DO - 10.1615/CritRevEukaryotGeneExpr.v15.i2.30

M3 - Article

C2 - 16022632

AN - SCOPUS:24644457061

VL - 15

SP - 115

EP - 132

JO - Critical Reviews in Eukaryotic Gene Expression

JF - Critical Reviews in Eukaryotic Gene Expression

SN - 1045-4403

IS - 2

ER -